SavedAdd your journal

Journals / Cukurova Medical Journal / 2022 / Cilt: 47 - Sayı: 4

Adalimumab induced severe paradoxical psoriasis in a patient with ankylosing spondylitis

Ankilozan spondilit tanılı hastada adalimumabın tetiklediği paradoksal psoriasis

Emre ZEKEY
Pinar KARABAGLİ
Gülcan SAYLAM KURTİPEK
Pages
1768–1770
Publication Date
2022-12-28
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this report, ankylosing spondylitis patient who developed severe paradoxical psoriasis while being treated with adalimumab was discussed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Anti-tumor necrosis factor (Anti-TNF)’s have been used frequently in rheumatology and dermatology.
📊
Key Findings & Data:These drugs may couse psoriasiform lesions paradoxically.
💡
Conclusion & Impact:In this report, ankylosing spondylitis patient who developed severe paradoxical psoriasis while being treated with adalimumab was discussed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Paradoksal Psoriasis · Adalimumab · Ankilozan Spondilit

Abstract

Anti-tumor necrosis factor (Anti-TNF)’s have been used frequently in rheumatology and dermatology. These drugs may couse psoriasiform lesions paradoxically. In this report, ankylosing spondylitis patient who developed severe paradoxical psoriasis while being treated with adalimumab was discussed.

Özet

Anti-tümör nekroz faktör ajanlar (Anti-TNF) romatoloji ve dermatoloji pratiğinde sıklıkla kullanılmaktadır. Bu ilaçlar paradoksal olarak psoriaziform lezyonlara neden olabilir. Bu bildiride adalimumab tedavisi sırasında şiddetli paradoksal psoriazis gelişen bir ankilozan spondilit hastası tartışılmıştır.

🔖

Cite This Article

ZEKEY, E., KARABAGLİ, P., KURTİPEK, G. S. (2022). Adalimumab induced severe paradoxical psoriasis in a patient with ankylosing spondylitis. Cukurova Medical Journal, Cilt: 47 - Sayı: 4, 1768–1770. https://ajindex.com/articles/858437

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Conrad C, Di Domizio J, Mylonas A, Belkhodja C, Demaria O, Navarini AA, et al. TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis. 2018;9(1):1-11
  2. Soumelis V, Liu YJJEjoi. From plasmacytoid to dendritic cell: morphological and functional switches during plasmacytoid pre‐dendritic cell differentiation. 2006;36(9):2286-92
  3. Mylonas A, Conrad CJFii. Psoriasis: Classical vs. paradoxical. The Yin-Yang of TNF and type I interferon. 2018;9:2746
  4. Cleynen I, Vermeire SJNrG, hepatology. Paradoxical inflammation induced by anti-TNF agents in patients with IBD. 2012;9(9):496-503
  5. Brown G, Wang E, Huynh M, Wehner M, Matro R, Linos E, et al. Tumor necrosis factor-α inhibitor-induced psoriasis: systematic review of clinical features, histopathological findings, and management experience. 2017;76(2):334-41
  6. Nestle FO, Conrad C, Tun-Kyi A, Homey B, Gombert M, Boyman O, et al. Plasmacytoid predendritic cells initiate psoriasis through interferon-α production. 2005;202(1):135-43
  7. Ko JM, Gottlieb AB, Kerbleski JFJJoDT. Induction and exacerbation of psoriasis with TNF-blockade therapy: a review and analysis of 127 cases. 2009;20(2):100-8
  8. Benzaquen M, Flachaire B, Rouby F, Berbis P, Guis SJRI. Paradoxical pustular psoriasis induced by ustekinumab in a patient with Crohn’s disease-associated spondyloarthropathy. 2018;38(7):1297-9
  9. Puig L, Morales-Múnera CE, López-Ferrer A, Geli CJD. Ustekinumab treatment of TNF antagonist-induced paradoxical psoriasis flare in a patient with psoriatic arthritis: case report and review. 2012;225(1):14-7
  10. Li SJ, Perez-Chada LM, Merola JFJJop, arthritis p. TNF inhibitor-induced psoriasis: proposed algorithm for treatment and management. 2019;4(2):70-80.